SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-24-005362
Filing Date
2024-04-19
Accepted
2024-04-19 16:05:18
Documents
8
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20240611xpre14a.htm PRE 14A 1315990
2 GRAPHIC tmb-20240611xpre14a_a001.jpg GRAPHIC 9601
3 GRAPHIC tmb-20240611xpre14a_a002.jpg GRAPHIC 5032
4 GRAPHIC tmb-20240611xpre14a_a003.jpg GRAPHIC 10983
5 GRAPHIC tmb-20240611xpre14a_a008.jpg GRAPHIC 56703
6 GRAPHIC tmb-20240611xpre14a_a009.jpg GRAPHIC 49124
7 GRAPHIC tmb-20240611xpre14a_bg001.jpg GRAPHIC 169866
8 GRAPHIC tmb-20240611xpre14a_bg002.jpg GRAPHIC 116560
  Complete submission text file 0001558370-24-005362.txt   1893678
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38150 | Film No.: 24857743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)